A0A8C6D5M4 (A0A8C6D5M4_MOSMO) Moschus moschiferus (Siberian musk deer) (Moschus sibiricus)
cAMP-dependent protein kinase catalytic subunit alpha UniProtKBInterProInteractive Modelling
351 aa; Sequence (Fasta) ;
4 identical sequences: Bos indicus: A0A6P5C1U0; Bos taurus: P00517; Bos indicus x Bos taurus: A0A4W2GDJ9; Bos mutus grunniens: A0A8B9YI28
It is possible new templates exist for this target since these models were created.
Available Structures
95 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Protein kinase A variant complex with completely ordered N-terminal helix |
Heteromer P00517; P61926; | 98.86 | 6×BU3; 1×MG8; | |||
| Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mu… |
Heteromer P00517; P61925; | 98.86 | 1×R68; | |||
| The Catalytic Subunit of cAMP-dependent Protein Kinase in Complex with Rho-kinase Inhibitor H-1152P |
Heteromer P00517; P63249; | 100 | 2×H52; 1×MG8; | |||
| The Synthesis and Evaluation of Diazaspirocyclic Protein Kinase Inhibitors |
Heteromer P00517; Q3SX13; | 100 | 1×15I; 2×GOL; 1×MPD; | |||
| Crystal structures of the kinase domain of PKA in complex with ATP-competitive inhibitors |
Heteromer P00517; Q3SX13; | 100 | 1×G98; | |||
| Crystal structures of the kinase domain of PKA in complex with ATP-competitive inhibitors |
Heteromer P00517; Q3SX13; | 100 | 1×G96; | |||
| Crystal Structure of Protein Kinase A in Complex with Azepane Derivative 1 |
Heteromer P00517; P61926; | 100 | 1×NA; 1×I01; 1×MG8; | |||
| Structure of PKA-PKB chimera complexed with C-(4-(4-Chlorophenyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4-y… |
Heteromer P00517; P61925; | 98.83 | 1×CL; 1×MRD; 2×EDO; 2×M03; | |||
| The Synthesis and Evaluation of Diazaspirocyclic Protein Kinase Inhibitors |
Heteromer P00517; Q3SX13; | 100 | 1×SIJ; 4×GOL; 2×MOH; | |||
| PKA-S6K1 Chimera with Staurosporine bound |
Heteromer P00517; Q3SX13; | 98.53 | 1×STU; 1×GOL; 1×MG8; | |||
| Protein kinase A fivefold mutant model of Rho-kinase |
Heteromer P00517; P63248; | 98.53 | ||||
| The Catalytic Subunit of cAMP-dependent Protein Kinase (PKA) in Complex with Rho-kinase Inhibitor Y… |
Heteromer P00517; P61925; | 100 | 1×Y27; | |||
| Crystal Structure of Protein Kinase A in Complex with Azepane Derivative 4 |
Heteromer P00517; P61926; | 100 | 1×I04; | |||
| PKA five fold mutant model of Rho-kinase with H1152P |
Heteromer P00517; P61926; | 98.53 | 2×H52; | |||
| PKA-S6K1 Chimera with compound 1 (NU1085) bound |
Heteromer P00517; Q3SX13; | 98.53 | 1×NU3; 1×MPD; | |||
| PKA fivefold mutant model of Rho-kinase with inhibitor Fasudil (HA1077) |
Heteromer P00517; P61925; | 98.53 | 1×M77; | |||
| Protein kinase A fivefold mutant model of Rho-kinase with Y-27632 |
Heteromer P00517; P63248; | 98.53 | 1×Y27; | |||
| Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mu… |
Heteromer P00517; P61925; | 100 | 1×R96; | |||
| Crystal Structure of Protein Kinase A in Complex with Azepane Derivative 5 |
Heteromer P00517; P61925; | 100 | 1×I05; | |||
| The Synthesis and Evaluation of Diazaspirocyclic Protein Kinase Inhibitors |
Heteromer P00517; Q3SX13; | 100 | 1×QNI; 7×MOH; 4×GOL; | |||
| PKA threefold mutant model of Rho-kinase with inhibitor H-1152P |
Heteromer P00517; P61926; | 99.12 | 1×H52; | |||
| Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mu… |
Heteromer P00517; P61925; | 100 | 1×R55; | |||
| Structure of bovine PKA bound to (R)-N-(4-(1H-pyrrolo[2,3-b]pyridin-4-yl)phenyl)-2-amino-4-methylpe… |
Heteromer P00517; Q3SX13; | 100 | 1×ZWG; | |||
| Dephosphorylated CFTR in 1:1 complex with PKA-C (site II) |
Heteromer P00517; P13569; | 100.0 | ||||
| Phosphorylated (E1371Q)CFTR in complex with PKA-C |
Heteromer P00517; P13569; | 100.0 | 1×CLR; 4×D10; 4×MG; 3×ATP; 4×CL; 3×UND; | |||
| Dephosphorylated CFTR in 1:2 complex with PKA-C |
Heteromer P00517; P13569; | 100.0 | 2×MG; 1×ANP; | |||
| Dephosphorylated CFTR in 1:1 complex with PKA-C (site I) |
Heteromer P00517; P13569; | 100.0 | 2×MG; 1×ANP; | |||
| Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mu… |
Heteromer P00517; P61925; | 98.52 | 1×R69; 3×BU3; | |||
| PKA-S6K1 Chimera Apo |
Heteromer P00517; Q3SX13; | 98.52 | ||||
| PKA-S6K1 Chimera with compound 21a (CCT196539) bound |
Heteromer P00517; Q3SX13; | 98.52 | 1×Z21; 1×MPD; | |||
| Structure of PKA with a protein Kinase B-selective inhibitor. |
Heteromer P00517; | 100 | 1×B99; | |||
| Structure of PKA-PKB chimera complexed with 4-(4-Chlorobenzyl)-1-(7H- pyrrolo(2,3-d)pyrimidin-4-yl)… |
Heteromer P00517; P61925; | 98.82 | 1×CL; 1×M05; | |||
| PKA-S6K1 Chimera with compound 15e (CCT147581) bound |
Heteromer P00517; Q3SX13; | 98.52 | 1×ZO9; 1×MOH; | |||
| cAMP-dependent protein kinase PKA catalytic subunit with PKI-5-24 |
Heteromer P00517; P61926; | 99.7 | 1×LL1; | |||
| PKA double mutant model of PKB |
Heteromer P00517; P61925; | 99.41 | ||||
| PKAB3 in complex with pyrrolidine inhibitor 34a |
Heteromer P00517; P61925; | 99.11 | 1×NVX; 2×MOH; | |||
| PKA-S6K1 Chimera with compound 21e (CCT239066) bound |
Heteromer P00517; Q3SX13; | 98.52 | 1×VUP; 3×MOH; | |||
| The Synthesis and Evaluation of Diazaspirocyclic Protein Kinase Inhibitors |
Heteromer P00517; Q3SX13; | 100 | 1×MPD; 1×QWI; 1×GOL; 1×DMS; | |||
| PKAB3 in complex with pyrrolidine inhibitor 47a |
Heteromer P00517; P61925; | 99.11 | 2×4L7; | |||
| cAMP-dependent protein kinase PKA catalytic subunit with PKI-5-24 |
Heteromer P00517; P61926; | 100 | 1×OCT; | |||
| Structure of PKA-PKB chimera complexed with (1S)-2-amino-1-(4- chlorophenyl)-1-(4-(1H-pyrazol-4-yl)… |
Heteromer P00517; P61925; | 98.81 | 1×RKD; | |||
| Bovine PKA C-alpha in complex with 3-pyridylmethyl-5-methyl-1H-pyrazole-3-carboxylate |
Heteromer P00517; P61925; | 100 | 1×PZX; 1×GOL; | |||
| Structure of PKA-PKB chimera complexed with C-Phenyl-C-(4-(9H-purin-6- yl)-phenyl)-methylamine |
Heteromer P00517; P61925; | 98.81 | 1×GVJ; | |||
| Structure of cAMP-dependent protein kinase complexed with Isoquinoline-5-sulfonic acid (2-(2-(4-chl… |
Heteromer P00517; P61925; | 100 | 1×I5S; | |||
| Crystal structure of Protein Kinase A in complex with the PKI peptide and Aminobenzothiazole based … |
Heteromer P00517; Q3SX13; | 100.0 | 1×9D4; | |||
| Structure of PKA-PKB chimera complexed with (1-(9H-Purin-6-yl) piperidin-4-yl)amine |
Heteromer P00517; P61925; | 98.81 | 1×M02; | |||
| Structure of PKA-PKB chimera complexed with C-(4-(4-Chlorophenyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4-y… |
Heteromer P00517; P61925; | 98.81 | 1×CL; 1×M04; | |||
| Structure of PKA complexed with 4-(4-Chlorobenzyl)-1-(7H-pyrrolo(2,3- d)pyrimidin-4-yl)piperidin-4-… |
Heteromer P00517; P61925; | 100 | 2×M05; | |||
| Structure of cAMP-dependent protein kinase complexed with A-443654 |
Heteromer P00517; P61925; | 100 | 1×L20; | |||
| Structure of PKA-PKB chimera complexed with 7-azaindole |
Heteromer P00517; P61925; | 98.81 | 1×GVH; | |||
| Structure of PKA-PKB chimera complexed with 2-(4-chloro-phenyl)-2- phenyl-ethylamine |
Heteromer P00517; P61925; | 98.81 | 1×GVQ; | |||
| Structure of PKA-PKB chimera complexed with 6-(4-(4-(4-Chloro-phenyl) -piperidin-4-yl)-phenyl)-9H-p… |
Heteromer P00517; P61925; | 98.81 | 1×GVK; | |||
| Structure of cAMP-dependent protein kinase complexed with (4R,2S)-5'-(4-(4-Chlorobenzyloxy)pyrrolid… |
Heteromer P00517; P61925; | 100 | 1×CQP; | |||
| Structure of PKA-PKB chimera complexed with 2-(4-(5-methyl-1H-pyrazol- 4-yl)-phenyl)-ethylamine |
Heteromer P00517; P61925; | 98.81 | 1×L15; | |||
| Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mu… |
Heteromer P00517; P61925; | 100 | 1×R68; 3×BU3; | |||
| Structure of PKA-PKB chimera complexed with (1-(9H-Purin-6-yl) piperidin-4-yl)methanamine |
Heteromer P00517; P61925; | 98.81 | 1×M01; | |||
| Structure of PKA-PKB chimera complexed with 4-(4-chloro-phenyl)-4-(4- (1H-pyrazol-4-yl)-phenyl)-pip… |
Heteromer P00517; P61925; | 98.81 | 1×GVP; | |||
| PKA triple mutant model of PKB |
Heteromer P00517; P61925; | 99.11 | 1×MG8; | |||
| CAMP-DEPENDENT PROTEIN KINASE PKA CATALYTIC SUBUNIT WITH PKI-5-24 |
Heteromer P00517; P61926; | 99.7 | 1×EMU; | |||
| Structure of PKA-PKB chimera complexed with 5-methyl-4-phenyl-1H- pyrazole |
Heteromer P00517; P61925; | 98.81 | 1×GVG; | |||
| The Catalytic Subunit of cAMP-dependent Protein Kinase in Complex with Rho-kinase Inhibitor Fasudil… |
Heteromer P00517; P61926; | 100 | 1×M77; | |||
| Structure of PKA-PKB chimera complexed with (S)-2-(4-chloro-phenyl)- 2-(4-1H-pyrazol-4-yl)-phenyl)-… |
Heteromer P00517; P61925; | 98.81 | 1×GVO; | |||
| PKA three fold mutant model of Rho-kinase with Y-27632 |
Heteromer P00517; Q3SX13; | 99.11 | 1×Y27; | |||
| Crystal Structure of Protein Kinase A in Complex with Azepane Derivative 8 |
Heteromer P00517; P63249; | 100 | 1×I08; | |||
| Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mu… |
Heteromer P00517; P61925; | 100 | 1×R69; | |||
| Bovine PKA C-alpha in complex with 2-[[5-(4-pyridyl)-1H-1,2,4-triazol-3-yl]sulfanyl]-1-(2-thiopheny… |
Heteromer P00517; P61925; | 100 | 1×PTV; | |||
| PKA double mutant model of PKB in complex with MgATP |
Heteromer P00517; Q71U53; | 99.41 | 1×MG; 1×ATP; | |||
| Protein Kinase A bound to (S)-2-(1H-Indol-3-yl)-1-[5-((E)-2-pyridin-4-yl-vinyl)-pyridin-3-yloxymeth… |
Heteromer P00517; Q71U53; | 100 | 1×4EA; | |||
| Structure of PKA-PKB chimera complexed with methyl-(4-(9H-purin-6-yl)- benzyl)-amine |
Heteromer P00517; P61925; | 98.81 | 1×GVI; | |||
| PKA complexed with (S)-2-(1H-Indol-3-yl)-1-(5-isoquinolin-6-yl-pyridin-3-yloxymethyl-etylamine |
Heteromer P00517; P61925; | 100 | 1×2EA; | |||
| CRYSTAL STRUCTURE OF PKA IN COMPLEX WITH inhibitor. |
Heteromer P00517; Q3SX13; | 99.7 | 1×0RW; | |||
| Structure of PKA-PKB chimera complexed with A-443654 |
Heteromer P00517; P61925; | 98.81 | 1×L20; | |||
| PKA structures of AKT, indazole-pyridine inhibitors |
Heteromer P00517; Q3SX13; | 99.7 | 1×SS3; | |||
| Crystal structure of Protein Kinase A in complex with Pyridine-Pyrazolopyridine based inhibitors |
Heteromer P00517; | 100 | 1×4PY; | |||
| Structure of PKA-PKB chimera complexed with (R)-2-(4-chloro-phenyl)- 2-(4-1H-pyrazol-4-yl)-phenyl)-… |
Heteromer P00517; P61925; | 98.81 | 1×GVN; | |||
| Structure of PKA-PKB chimera complexed with ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) … |
Heteromer P00517; P61925; | 98.81 | 1×I5S; | |||
| Structure of CAMP-dependent protein kinase, alpha-catalytic subunit in complex with H8 protein kina… |
Heteromer P00517; P63249; | 99.41 | 1×IQS; | |||
| STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H7 PROTEIN KINA… |
Heteromer P00517; P61925; | 99.41 | 1×IQP; | |||
| PKA structures of indazole-pyridine series of AKT inhibitors |
Heteromer P00517; Q3SX13; | 99.7 | 1×SS4; | |||
| Crystal structure of Protein Kinase A in complex with Pyridine-Pyrazolopyridine Based Inhibitors |
Heteromer P00517; | 100 | 1×2PY; | |||
| cAMP-dependent protein kinase PKA catalytic subunit with PKI-5-24 |
Heteromer P00517; P61926; | 99.7 | 1×LL2; | |||
| CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH STAUROSPORINE |
Heteromer P00517; P61926; | 100 | 1×STU; | |||
| STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H89 PROTEIN KIN… |
Heteromer P00517; P63249; | 99.41 | 1×IQB; | |||
| PKA structures of indazole-pyridine series of AKT inhibitors |
Heteromer P00517; Q3SX13; | 99.7 | 1×L20; | |||
| PKA structures of indazole-pyridine series of AKT inhibitors |
Heteromer P00517; Q3SX13; | 99.7 | 1×SS5; | |||
| Protein Kinase A bound to (R)-1-(1H-Indol-3-ylmethyl)-2-(2-pyridin-4-yl-[1,7]naphtyridin-5-yloxy)-e… |
Heteromer P00517; P61926; | 100 | 1×6EA; | |||
| Crystal structure of Protein Kinase A in complex with the PKI peptide and a pyridinylbenzamide base… |
Heteromer P00517; P61925; | 100 | 1×J0P; | |||
| Crystal structure of Protein Kinase A in complex with the PKI peptide and Aminobenzothiazole based … |
Heteromer P00517; Q3SX13; | 100.0 | 1×9CY; | |||
| Crystal structure of Protein Kinase A in complex with the PKI peptide and an amino-pyridinylbenzami… |
Heteromer P00517; P61925; | 100 | 1×J0G; | |||
| Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mu… |
Heteromer P00517; P61925; | 100 | 1×R94; | |||
| Crystal structure of Protein Kinase A in complex with the PKI peptide and Aminobenzothiazole based … |
Heteromer P00517; Q3SX13; | 100.0 | 1×9D1; | |||
| Dephosphorylated (E1371Q)CFTR in complex with PKA-C |
Heteromer P00517; P13569; | 100.0 | 2×B44; 4×MG; 1×ANP; | |||
| Complex of PKA with the bisubstrate protein kinase inhibitor lead compound Arc-1034 | monomer | 100 | 2×ARX; | |||
| Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1012 | monomer | 100.0 | ||||
| DUAL BINDING MODE OF BISINDOLYLMALEIMIDE 2 TO PROTEIN KINASE A (PKA) | monomer | 99.06 | 1×BI4; | |||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2jds.1.A | monomer | 0.89 | 1×L20; | 100.00 | ||
| 3k3i.1.A | monomer | 0.62 | 25.27 | |||